Introduction to ARISE 2024
The ARISE Consensus Conferences, via a collaboration of medical academia, the healthcare industry and government agencies, are intended to advance and accelerate research in the treatment of intracranial hemorrhage (ICH), intracranial atherosclerotic disease (ICAD), and cerebral venous diseases (CVD), to ultimately result in improved acute and elective management, treatment, and prevention. To achieve this goal, ARISE 2024 will:
Latest Updates
Recent & ongoing research studies, novel therapeutics
Get Inspired
Hear cutting-edge research, ask questions and provide your feedback
Meet Stakeholders
Academia, Funding/Regulatory agencies, Industry
Change the future
Help improve acute stroke treatment, care, and prevention.
WHY ATTEND
The ARISE architecture encompasses 3 primary stakeholders involved in advancing research and practice for treating cerebrovascular disease: academia, comprising leading international physicians and scientists across relevant disciplines; industry, involving scientists and executives from private-sector pharmaceutical, device, and imaging companies; and regulatory institutions, consisting of executive managers, physicians, and scientists from esteemed organizations like the NIH and FDA.
LEARN MORE